Health Canada is informing Canadians that Marcan Pharmaceuticals has recalled all lots of all MAR-Diltiazem CD products in response to data integrity concerns that could lead to incorrect dosing. HMC
Tag: drug
Post
Health Canada warns Canadians about U-Dream herbal sleep-aid products after tests detect a substance similar to a prescription insomnia drug, which may pose serious health risks.
Health Canada is advising Canadians that it has tested several U-Dream Lite and U-Dream Full Night herbal sleep-aid products and has found that they contain a substance similar to the prescription drug zopiclone, which may pose serious health risks. The Department has suspended all of the company’s U-Dream and U-Dreams product licences, which means it...
Post
Finasteride (Proscar& Propecia)
Health Canada InfoWatch: New information regarding the risk of muscle-related disorders has been added to the Post-Market Adverse Drug Reactions and Consumer Information sections of the Canadian product monographs for Proscar and Propecia. Key messages for healthcare professionals: Rare cases of muscle-related disorders, such as rhabdomyolysis, myopathy, myalgia, myasthenia, and creatine kinase elevation, have been...
Post
Discontinuation of Amaryl
Sanofi-aventis Canada announced in June, 2018 that it will immediately stop the distribution of Amaryl (Glimipiride) 1,2 and 4mg tabs in Canada. Glimepiride (original trade name Amaryl) is an orally available medium-to-long-acting Sulfonylurea antidiabetic drug.